Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack

Cephalalgia

Volumn 25, Issue 5, 2005, Pages 359-368

  De Tommaso, Marina ^a   Losito, L ^a   Libro, G ^a   Guido, M ^a   Di Fruscolo, O ^a   Sardaro, M ^a   Sciruicchio, V ^a   Lamberti, P ^a   Livrea, P ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Central sensitization; Laser evoked potentials; Migraine; Symptomatic treatment

Indexed keywords

ALMOTRIPTAN; LYSINE ACETYLSALICYLATE; PLACEBO;

ADULT; AMPLITUDE MODULATION; ARTICLE; CARBON DIOXIDE LASER; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; ELECTRODE; EMOTION; EVOKED RESPONSE; FEMALE; HUMAN; HYPERALGESIA; LASER; MIGRAINE; NOCICEPTION; PAIN THRESHOLD; SENSITIZATION; SYMPTOMATOLOGY;

ADULT; ASPIRIN; EVOKED POTENTIALS; FEMALE; HEAT; HUMANS; HYPERALGESIA; INDOLES; LASERS; LYSINE; MIDDLE AGED; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 17644428067     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2004.00866.x     Document Type: Article

References (25)

1. Burstein R, Cutrer FM, Yarnitsky D. The development of cutaneous allodynia during a migraine attack, clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000; 123:1703-9.
2. Bromm B, Treede RD. Laser-evoked cerebral potentials in the assessment of cutaneous pain sensitivity in normal subjects and patients. Rev Neurol 1991; 147:625-43.
3. de Tommaso M, Guido M, Libro G, Losito L, Sciruicchio V, Monetti C, et al. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neurosci Lett 2002; 333:29-32.
4. Cumberbatch MJ, Williamson DJ, Mason GS, Hill RG, Hargreaves RJ. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol 1999; 126:1478-86.
5. Bingham S, Davey PT, Sammons M, Raval P, Overend P, Parsons AA. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT (1B/1D) receptors. Exp Neurol 2001; 167:65-73.
6. de Tommaso M, Guido M, Libro G, Sciruicchio V, Puca F. Zolmitriptan reverses blink reflex changes induced during the migraine attack in humans. Neurosci Lett 2000; 28:57-60.
7. Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener HC. Acute migraine headache: possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 2002; 23:1234-8.
8. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004; 55:27-36.
9. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55:19-26.
10. Headache Classification Subcommittee of the international Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004; 24 Suppl 1:1-160.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Association, 1994.
12. D'Amico D, Mosconi P, Genco S, Usai S, Prudenzano AM, Grazzi L, et al. The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version. Cephalalgia 2001; 21:947-52.
13. International Headache Society Committee on Clinical trials in migraine. Guidelines for controlled trials of drugs in migraine. Cephalalgia 1991; 11:1-12.
14. 2 laser skin stimulation of the hand and foot in the human brain. Clin Neurophysiol 2000; 111:1103-12.
15. Valeriani M, Arendt-Nielsen L, Le Pera D, Restuccia D, Rosso T, De Armas L, et al. Short-term plastic changes of the human nociceptive system following acute pain induced by capsaicin. Clin Neurophysiol 2003; 114:1879-90.
16. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001; 89:107-10.
17. Gibson SJ, Gorman MM, Helme RD. Assessment of pain in the elderly using event-related cerebral potentials. Pain research and clinical management. In: Bond MR, Charlton JE & Woolf CJ, editors. Proceedings of the VIth World Congress on Pain. Amsterdam: Elsevier, 1991:523-9.
18. Beydoun A, Morrow TJ, Schen JF, Casey JF, Casey KL. Variability of laser-evoked potentials: attention, arousal and lateralized differences. Electroenceph Clin Neurophysiol 1999; 839:203-8.
19. Fields HL, Bashaum AI. Central nervous system mechanisms of pain modulation,. In: Wall PD, Melzack R, editors. Textbook of Pain, 4. London: Churchill Livingstone, 1999.
20. de Tommaso M, Valeriani M, Guido M, Libro G, Specchio LM et al. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain 2003; 101:25-32.
21. Treede RD, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials Neurophysiol Clin 2003; 33:303-14.
22. Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache 1993; 33:541-4.
23. Vergne P, Bertin P, Treves R. Aspirin, pain and inflammation. Rev Med Interne 2000; 21:89-96.
24. Pascual J. Almotriptan: pharmacological differences and clinical results. J Curr Med Res Opin 2001; 17:63-7.
25. Dodick DW. A review of the clinical efficacy and tolerability of almotriptan in acute migraine. Expert Opin Pharmacother 2003; 4:1157-63.